Affinity Asset Advisors’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.79M Buy
2021
Q4
Sell
2021
Q3
$7.5M Buy
2021
Q2
$3.54M Buy
2021
Q1
$3.73M Buy
2020
Q4
$4.55M Buy